Zobrazeno 1 - 10
of 14
pro vyhledávání: '"A. F. Joslyn"'
Publikováno v:
Neurogastroenterology & Motility. 3:46-52
Changes in cyclic nucleotide content arc associated with relaxation of lower esophageal sphincter (LES) smooth muscle. Although agents that increase cyclic AMP (cAMP) or cyclic CMP (cGMP) can relax the LES, relaxation produced by activation of enteri
Autor:
M Grous, M S Barnette, W. J. Price, W. E. Thompson, M. Fudge, F. C. Barone, A. F. Joslyn, H. S. Ormsbee, C. D. Manning
Publikováno v:
Neurogastroenterology & Motility. 2:65-72
Neuronal stimulation of most isolated precontracted gastrointestinal smooth muscle results in relaxation. This study examined the changes in cyclic nucleotide content associated with neuronally induced relaxation in sphincteric and nonsphincteric smo
Autor:
Michael H. Pearman, Fred M. Cox, Samia N. Khalil, Anthony L. Kovac, Barbara A. Prillaman, Alan F. Joslyn, Phillip E. Scuderi
Publikováno v:
Journal of Clinical Anesthesia. 8:644-651
Study Objectives: To determine (1) the efficacy and safety of ondansetron in the prevention of postoperative nausea and vomiting (PONV) in male outpatients; (2) prognostic factors for PONV in male outpatients; and (3) patients' perceptions of the deb
Autor:
A. F. Joslyn
Publikováno v:
Anaesthesia. 49:34-37
The clinical development of ondansetron for the prevention and treatment of postoperative nausea and vomiting has been progressing for 5 years, and continues as new directions of research are being addressed. Large multicentre studies have demonstrat
Autor:
Julius R. Bowie, Alan F. Joslyn, Jennifer Lessin, Boonrak Tantisira, Rafael Miguel, Mark Dershwitz, John B. Downs, Carl E. Rosow, Fred Rosenblum, Patricia M. DiBiase, Ray McKenzie, Stephen Odell, Kevin Sheahan, Mary Nations, Said Sharifi-Azad
Publikováno v:
Journal of Clinical Anesthesia. 5:30-36
To compare the efficacy and safety profiles of intravenous (IV) ondansetron (two 8 mg doses 8 hours apart) and a placebo when used in the prevention of postoperative nausea and emesis (vomiting or retching).Randomized, double-blind, placebo-controlle
Publikováno v:
Clinical Pharmacology and Therapeutics. 52:96-101
The efficacy of ondansetron, a selective 5-HT3 receptor antagonist, in preventing postoperative nausea and vomiting in surgical patients was studied. Fifty women were randomized in a double-blind manner to receive either two 8 mg doses of intravenous
Publikováno v:
Journal of clinical anesthesia. 8(8)
To determine (1) the efficacy and safety of ondansetron in the prevention of postoperative nausea and vomiting (PONV) in male outpatients; (2) prognostic factors for PONV in male outpatients; and (3) patients' perceptions of the debilitating effects
Publikováno v:
Journal of clinical anesthesia. 5(1)
Study Objective : To compare the efficacy and safety profiles of ondansetron and a placebo when infused immediately prior to anesthesia induction for the prevention of postoperative nausea and emesis (vomiting or retching). Design : Randomized, doubl
Autor:
A, Kovac, R, McKenzie, T, O'Connor, D, Duncalf, J, Angel, I, Gratz, I, Fagraeus, C, McLeskey, A F, Joslyn
Publikováno v:
European journal of anaesthesiology. Supplement. 6
The efficacy and safety of prophylactic intravenous ondansetron in preventing postoperative nausea and vomiting was investigated in a randomized, stratified, double-blind, placebo-controlled, dose-comparison study of 580 ASA physical class I and II f
Autor:
J P, Isal, C G, Haigh, K, Hellstern, F C, Inall, A F, Joslyn, B K, Kanarek, L A, Kaplan, P M, Povey
Publikováno v:
European journal of anaesthesiology. Supplement. 6
An international clinical trial programme has been established to assess the efficacy and safety of ondansetron in the prevention and treatment of postoperative nausea and vomiting. The programme included nine pilot studies and six key placebo-contro